Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?

Detalhes bibliográficos
Autor(a) principal: Souto, Bárbara Oliveira Vasconcelos
Data de Publicação: 2021
Outros Autores: Figueiredo, Bárbara Queiroz de, Silva, Andressa Caetano Martins, Coury, Bruno Faria, Durante, Gabriele, Amorim, Gardênia Silva, Silva, Gilvane Pereira da, Medeiros, Gustavo Alves, Miranda, Luana Damaceno, Oliveira, Nicolly Skarlet Souto, Oliveira, Rúbia Carla
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/18817
Resumo: Introduction: The ABO blood group is an example of evolutionary adaptation where, for thousands of years, microorganisms and humans interact in a symbiotic or pathological way, influencing the genetics of the populations and the evolution of the human genome by the natural selection of specific alleles capable of modifying pathogens. Objective: to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh together with various parameters in patients accompanied as a diagnosis of COVID-19. Methodology: This is a descriptive research of an integrative literature review type, which seeks to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh, together with various parameters in patients accompanied by a diagnosis of COVID-19. A research was carried out through online access to databases National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Biblioteca Virtual em Saúde (BVS) and EBSCO Information Services, no more than July 2021. Results: The most frequently observed blood type was or A + among patients with COVID-19. The Rh + blood group was found in all cases admitted to UTI with a fatal evolution. Or blood group A was associated with an increased risk of infection, or group O was associated with a reduced risk. Conclusion: There is no way to affirm the association of blood group A positive with COVID-19 with scientifically proven results in different populations. However, the association between blood groups and other past infections cannot be ignored.
id UNIFEI_8c9c988b9de572e187b504cface7e251
oai_identifier_str oai:ojs.pkp.sfu.ca:article/18817
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?Relación entre COVID-19 y el sistema sanguíneo ABO: ¿evidencia clara y suficiente?Relação entre COVID-19 e sistema sanguíneo ABO: evidências claras e suficientes?Sistema ABOCOVID-19Antígeno.ABO systemCOVID-19Antigen.Sistema ABOCOVID-19Antígeno. Introduction: The ABO blood group is an example of evolutionary adaptation where, for thousands of years, microorganisms and humans interact in a symbiotic or pathological way, influencing the genetics of the populations and the evolution of the human genome by the natural selection of specific alleles capable of modifying pathogens. Objective: to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh together with various parameters in patients accompanied as a diagnosis of COVID-19. Methodology: This is a descriptive research of an integrative literature review type, which seeks to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh, together with various parameters in patients accompanied by a diagnosis of COVID-19. A research was carried out through online access to databases National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Biblioteca Virtual em Saúde (BVS) and EBSCO Information Services, no more than July 2021. Results: The most frequently observed blood type was or A + among patients with COVID-19. The Rh + blood group was found in all cases admitted to UTI with a fatal evolution. Or blood group A was associated with an increased risk of infection, or group O was associated with a reduced risk. Conclusion: There is no way to affirm the association of blood group A positive with COVID-19 with scientifically proven results in different populations. However, the association between blood groups and other past infections cannot be ignored.Introducción: El grupo sanguíneo ABO es un ejemplo de adaptación evolutiva donde, durante miles de años, microorganismos y humanos interactuaron de forma simbiótica o patológica, influyendo en la genética de poblaciones y la evolución del genoma humano a través de la selección natural de alelos específicos capaces de modificar patogenia. Objetivo: analizar el significado pronóstico de los antígenos de los grupos sanguíneos ABO y Rh junto con diversos parámetros en pacientes seguidos con el diagnóstico de COVID-19. Metodología: Se trata de una revisión descriptiva integradora de la literatura, que buscó analizar la significación pronóstica de los antígenos de los grupos sanguíneos ABO y Rh, junto con diversos parámetros en pacientes seguidos con el diagnóstico de COVID-19. La búsqueda se realizó a través del acceso online en la Biblioteca Nacional de Medicina (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) y bases de datos EBSCO Information Services, Julio de 2021. Resultados: El tipo de sangre observado con mayor frecuencia fue A + entre los pacientes con COVID-19. El grupo sanguíneo Rh + se encontró en todos los casos ingresados ​​en UCI y con evolución fatal. El grupo sanguíneo A se asoció con un mayor riesgo de infección, mientras que el grupo O se asoció con un riesgo reducido. Conclusión: No hay forma de afirmar la asociación del grupo sanguíneo A positivo con COVID-19 sin resultados científicamente probados en diferentes poblaciones. Sin embargo, no se puede ignorar la asociación entre grupos sanguíneos y otras infecciones en el pasado.Introdução: O grupo sanguíneo ABO é exemplo de adaptação evolutiva onde, por milhares de anos, microrganismos e humanos interagiram de forma simbiótica ou patológica, influenciando na genética das populações e na evolução do genoma humano pela seleção natural de alelos específicos capazes de modificar a patogênese. Objetivo: é analisar o significado prognóstico dos antígenos dos grupos sanguíneos ABO e Rh juntamente com vários parâmetros em pacientes acompanhados com o diagnóstico de COVID-19. Metodologia: Trata-se de uma pesquisa descritiva do tipo revisão integrativa da literatura, que buscou analisar o significado prognóstico dos antígenos dos grupos sanguíneos ABO e Rh, juntamente com vários parâmetros em pacientes acompanhados com o diagnóstico de COVID-19. A pesquisa foi realizada através do acesso online nas bases de dados National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Biblioteca Virtual em Saúde (BVS) e EBSCO Information Services, no mês de julho de 2021. Resultados: O tipo sanguíneo mais frequentemente observado foi o A + entre os pacientes com COVID-19. O grupo sanguíneo Rh + foi encontrado em todos os casos admitidos na UTI e com evolução mortal. O grupo sanguíneo A estava associado a um risco aumentado de infecção, enquanto o grupo O estava associado com um risco reduzido. Conclusão: Não há como afirmar a associação do grupo sanguíneo A positivo com COVID-19 sem resultados cientificamente comprovados em diferentes populações. No entanto, a associação entre grupos sanguíneos e outras infecções no passado não pode ser ignorada.Research, Society and Development2021-08-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1881710.33448/rsd-v10i10.18817Research, Society and Development; Vol. 10 No. 10; e188101018817Research, Society and Development; Vol. 10 Núm. 10; e188101018817Research, Society and Development; v. 10 n. 10; e1881010188172525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/18817/17200Copyright (c) 2021 Bárbara Oliveira Vasconcelos Souto; Bárbara Queiroz de Figueiredo; Andressa Caetano Martins Silva; Bruno Faria Coury; Gabriele Durante; Gardênia Silva Amorim; Gilvane Pereira da Silva; Gustavo Alves Medeiros; Luana Damaceno Miranda; Nicolly Skarlet Souto Oliveira; Rúbia Carla Oliveirahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSouto, Bárbara Oliveira VasconcelosFigueiredo, Bárbara Queiroz deSilva, Andressa Caetano MartinsCoury, Bruno FariaDurante, Gabriele Amorim, Gardênia SilvaSilva, Gilvane Pereira da Medeiros, Gustavo AlvesMiranda, Luana DamacenoOliveira, Nicolly Skarlet SoutoOliveira, Rúbia Carla2021-10-02T21:49:16Zoai:ojs.pkp.sfu.ca:article/18817Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:38:51.701428Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?
Relación entre COVID-19 y el sistema sanguíneo ABO: ¿evidencia clara y suficiente?
Relação entre COVID-19 e sistema sanguíneo ABO: evidências claras e suficientes?
title Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?
spellingShingle Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?
Souto, Bárbara Oliveira Vasconcelos
Sistema ABO
COVID-19
Antígeno.
ABO system
COVID-19
Antigen.
Sistema ABO
COVID-19
Antígeno.
title_short Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?
title_full Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?
title_fullStr Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?
title_full_unstemmed Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?
title_sort Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?
author Souto, Bárbara Oliveira Vasconcelos
author_facet Souto, Bárbara Oliveira Vasconcelos
Figueiredo, Bárbara Queiroz de
Silva, Andressa Caetano Martins
Coury, Bruno Faria
Durante, Gabriele
Amorim, Gardênia Silva
Silva, Gilvane Pereira da
Medeiros, Gustavo Alves
Miranda, Luana Damaceno
Oliveira, Nicolly Skarlet Souto
Oliveira, Rúbia Carla
author_role author
author2 Figueiredo, Bárbara Queiroz de
Silva, Andressa Caetano Martins
Coury, Bruno Faria
Durante, Gabriele
Amorim, Gardênia Silva
Silva, Gilvane Pereira da
Medeiros, Gustavo Alves
Miranda, Luana Damaceno
Oliveira, Nicolly Skarlet Souto
Oliveira, Rúbia Carla
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Souto, Bárbara Oliveira Vasconcelos
Figueiredo, Bárbara Queiroz de
Silva, Andressa Caetano Martins
Coury, Bruno Faria
Durante, Gabriele
Amorim, Gardênia Silva
Silva, Gilvane Pereira da
Medeiros, Gustavo Alves
Miranda, Luana Damaceno
Oliveira, Nicolly Skarlet Souto
Oliveira, Rúbia Carla
dc.subject.por.fl_str_mv Sistema ABO
COVID-19
Antígeno.
ABO system
COVID-19
Antigen.
Sistema ABO
COVID-19
Antígeno.
topic Sistema ABO
COVID-19
Antígeno.
ABO system
COVID-19
Antigen.
Sistema ABO
COVID-19
Antígeno.
description Introduction: The ABO blood group is an example of evolutionary adaptation where, for thousands of years, microorganisms and humans interact in a symbiotic or pathological way, influencing the genetics of the populations and the evolution of the human genome by the natural selection of specific alleles capable of modifying pathogens. Objective: to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh together with various parameters in patients accompanied as a diagnosis of COVID-19. Methodology: This is a descriptive research of an integrative literature review type, which seeks to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh, together with various parameters in patients accompanied by a diagnosis of COVID-19. A research was carried out through online access to databases National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Biblioteca Virtual em Saúde (BVS) and EBSCO Information Services, no more than July 2021. Results: The most frequently observed blood type was or A + among patients with COVID-19. The Rh + blood group was found in all cases admitted to UTI with a fatal evolution. Or blood group A was associated with an increased risk of infection, or group O was associated with a reduced risk. Conclusion: There is no way to affirm the association of blood group A positive with COVID-19 with scientifically proven results in different populations. However, the association between blood groups and other past infections cannot be ignored.
publishDate 2021
dc.date.none.fl_str_mv 2021-08-08
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/18817
10.33448/rsd-v10i10.18817
url https://rsdjournal.org/index.php/rsd/article/view/18817
identifier_str_mv 10.33448/rsd-v10i10.18817
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/18817/17200
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 10 No. 10; e188101018817
Research, Society and Development; Vol. 10 Núm. 10; e188101018817
Research, Society and Development; v. 10 n. 10; e188101018817
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052685943308288